U
MJN

UBS’s Mead Johnson Nutrition Company MJN Stock Holding History

UBS’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$19.4M Sell
201,972
-248,924
-55% -$23.6M 0.01% 968
2014
Q2 		$42M Buy
450,896
+83,559
+23% +$7.31M 0.03% 526
2014
Q1 		$30.5M Buy
367,337
+201,583
+122% +$16.3M 0.03% 595
2013
Q4 		$13.9M Sell
165,754
-24,967
-13% -$2.03M 0.01% 1040
2013
Q3 		$14.2M Buy
190,721
+59,065
+45% +$4.43M 0.01% 897
2013
Q2 		$10.4M Buy
+131,656
New +$10.6M 0.01% 1006

Other funds holding MJN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

UBS's MJN Position: Q3 2014 in Review

UBS reduced its Mead Johnson Nutrition Company (MJN) stake by 55% in Q3 2014, selling an estimated $23.6M and leaving 201,972 shares worth $19.4M. The position accounts for 0.01% of the portfolio, ranked #968.

UBS first reported a position in MJN in Q2 2013 and has held it in 6 quarters since. The position peaked at $42M in Q2 2014. 524 funds tracked by Wall St. Rank hold MJN as of Q3 2014.

  • UBS held 201,972 shares of Mead Johnson Nutrition Company worth $19.4M as of Q3 2014.
  • UBS sold 248,924 Mead Johnson Nutrition Company shares in Q3 2014, an estimated $23.6M.
  • Mead Johnson Nutrition Company made up 0.01% of UBS's portfolio in Q3 2014, its #968 holding.
  • UBS first reported a position in Mead Johnson Nutrition Company in Q2 2013 and has held it in 6 quarters since.
  • UBS's Mead Johnson Nutrition Company position peaked at $42M in Q2 2014.
  • 524 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.